A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens

J Gen Virol. 2007 Oct;88(Pt 10):2793-2799. doi: 10.1099/vir.0.83268-0.

Abstract

This report characterizes lentivirus attenuation associated with a vif mutation by inoculation of newborn kittens with a vif-deleted feline immunodeficiency virus provirus plasmid (FIV-pPPRDeltavif). Virus in peripheral blood, antiviral antibody or CD4 T-cell count alterations were not detected in kittens inoculated with FIV-pPPRDeltavif plasmid, with the exception of one kitten that demonstrated FIV Gag antibody production at 42 weeks after inoculation. In contrast, wild-type FIV-pPPR-infected kittens were viraemic, seropositive and exhibited a decrease in the CD4 T-cell subset in peripheral blood. Interestingly, FIV-specific T-cell proliferative responses detected at 32 and 36 weeks after infection were comparable for both FIV-pPPRDeltavif- and wild-type FIV-pPPR-inoculated kittens and suggested the possibility of a discreet tissue reservoir supporting sustained FIV-pPPRDeltavif expression or replication. Overall, these findings confirmed that the severe virus attenuation for both replication and pathogenicity exhibited by a vif-deleted FIV mutant is similar for both neonatal and adult hosts.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Antibodies, Viral / blood
  • CD4-Positive T-Lymphocytes / immunology
  • Cats / virology*
  • Feline Acquired Immunodeficiency Syndrome / immunology
  • Feline Acquired Immunodeficiency Syndrome / prevention & control*
  • Gene Deletion*
  • Gene Products, vif / deficiency*
  • Gene Products, vif / genetics*
  • Genome, Viral
  • Immunodeficiency Virus, Feline / genetics*
  • Immunodeficiency Virus, Feline / physiology
  • Mutation
  • Virus Replication

Substances

  • Antibodies, Viral
  • Gene Products, vif